Other languages 4basebio PLC

Equities

4BB

GB00BMCLYF79

Market Closed - London S.E. Other stock markets 11:35:21 2024-04-30 EDT			5-day change	1st Jan Change
1,070 ^GBX	0.00%		+2.39%	+57.35%

04-10	4basebio to supply synthetic DNA for mRNA vaccine program	AN
04-10	4Basebio plc Announces the Supply of Its opDNA? DNA Products into Tier 1 Pharma Client's Vaccine Program	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

4basebio to supply synthetic DNA for mRNA vaccine program	04-10
4Basebio plc Announces the Supply of Its opDNA? DNA Products into Tier 1 Pharma Client's Vaccine Program	04-10
4basebio updates markets on "key milestone" with client	03-21
Alpha Real Trust says in "robust" financial shape	03-01
4basebio wins DNA supply contract to support RNA therapies	03-01
4basebio Wins Synthetic DNA Supply Tender from CPI	03-01
4basebio interim loss widens as research costs increase	23-09-21
4basebio PLC Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-21
4basebio PLC Receives A Grant from the Bill & Melinda Gates Foundation to Advance the Development Program of Thermostable Nucleic Acid Based Vaccines	23-08-01
4basebio PLC and Neomatrix Announce Product Supply Agreement	23-05-25
4basebio PLC Reports Earnings Results for the Full Year Ended December 31, 2022	23-05-11
4basebio PLC Announces Further Expansion of Its UK Facilities	23-04-03
4basebio PLC Reports Earnings Results for the Half Year Ended June 30, 2022	22-09-30
4basebio PLC Announces Collaboration with University of Alabama and Teesside University	22-06-10
4basebio PLC Reports Earnings Results for the Full Year Ended December 31, 2021	22-05-09
4basebio PLC Announces Joint Development Agreement with Heqet Therapeutics	22-04-27
4basebio PLC Announces the Expansion of its Synthetic DNA Product Offering	22-03-23
4basebio PLC Appoints Mark Cooper as Head of Manufacturing	22-02-15
4Basebio Discovery Limited and Etherna Immunotherapies Enters into Strategic Research Collaboration	22-01-18
4Basebio UK Societas Reports Consolidated Earnings Results for the Year Ended 31 December 2020	21-06-03

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages 4basebio PLC

Equities

4BB

GB00BMCLYF79

Other languages

Filters